Fabry disease (FD) is a treatable cause of hypertrophic cardiomyopathy (HCM). We aimed to determine the independent predictors of FD and to define a clinically useful strategy to discriminate FD among HCM.Shire Human Genetic Therapies, Inc.info:eu-repo/semantics/publishedVersio
[[abstract]]Fabry disease (FD) is an X-linked, rare inherited lysosomal storage disease caused by al...
Hypertrophic cardiomyopathy (HCM) is the most common known inherited heart disorder, with a prevalen...
Background—Fabry disease (FD) has been recognized as the cause of left ventricular hypertrophy in 6%...
Fabry disease (FD) is a treatable cause of hypertrophic cardiomyopathy (HCM). We aimed to determine ...
This study aimed to develop a new set of screening criteria that is easily applicable and highly sen...
Abstract Although Fabry disease was identified a century ago, it is still a challenging condition to...
ObjectivesWe aimed to study the prevalence of Fabry disease (FD) in patients with hypertrophic cardi...
BACKGROUND: The present study aimed to identify the frequency of Fabry disease in patients with card...
International audiencePURPOSE:To evaluate the potential of non-contrast myocardial T1 mapping on car...
Aims: Fabry disease is an X-linked lysosomal storage disorder due to a deficiency of the alpha-galac...
BACKGROUND: Screening in subjects with left ventricular hypertrophy (LVH) reveals a high prevalence ...
The prevalence of Anderson-Fabry disease (AFD) in patients presenting with unexplained left ventricu...
Fabry disease (FD) is an X-linked lysosomal storage disorder caused by mutations in the galactosidas...
Screening in subjects with left ventricular hypertrophy (LVH) reveals a high prevalence of Fabry dis...
AbstractBackgroundThe prevalence of Fabry disease (FD) in Japanese patients presenting with unexplai...
[[abstract]]Fabry disease (FD) is an X-linked, rare inherited lysosomal storage disease caused by al...
Hypertrophic cardiomyopathy (HCM) is the most common known inherited heart disorder, with a prevalen...
Background—Fabry disease (FD) has been recognized as the cause of left ventricular hypertrophy in 6%...
Fabry disease (FD) is a treatable cause of hypertrophic cardiomyopathy (HCM). We aimed to determine ...
This study aimed to develop a new set of screening criteria that is easily applicable and highly sen...
Abstract Although Fabry disease was identified a century ago, it is still a challenging condition to...
ObjectivesWe aimed to study the prevalence of Fabry disease (FD) in patients with hypertrophic cardi...
BACKGROUND: The present study aimed to identify the frequency of Fabry disease in patients with card...
International audiencePURPOSE:To evaluate the potential of non-contrast myocardial T1 mapping on car...
Aims: Fabry disease is an X-linked lysosomal storage disorder due to a deficiency of the alpha-galac...
BACKGROUND: Screening in subjects with left ventricular hypertrophy (LVH) reveals a high prevalence ...
The prevalence of Anderson-Fabry disease (AFD) in patients presenting with unexplained left ventricu...
Fabry disease (FD) is an X-linked lysosomal storage disorder caused by mutations in the galactosidas...
Screening in subjects with left ventricular hypertrophy (LVH) reveals a high prevalence of Fabry dis...
AbstractBackgroundThe prevalence of Fabry disease (FD) in Japanese patients presenting with unexplai...
[[abstract]]Fabry disease (FD) is an X-linked, rare inherited lysosomal storage disease caused by al...
Hypertrophic cardiomyopathy (HCM) is the most common known inherited heart disorder, with a prevalen...
Background—Fabry disease (FD) has been recognized as the cause of left ventricular hypertrophy in 6%...